Mucosta Interstitial Lung Disease Side Effect Reports
The following Mucosta Interstitial Lung Disease side effect reports were submitted by healthcare professionals and consumers.
This information will help you understand how side effects, such as Interstitial Lung Disease, can occur, and what you can do about them.
A side effect could appear soon after you start Mucosta or it might take time to develop.
|Dyspnoea Exertional, Interstitial Lung Disease, Oedema, Decreased Appetite, Platelet Count Decreased, Blood Creatinine Increased, Blood Uric Acid Increased|
This Interstitial Lung Disease side effect was reported by a physician from JAPAN. A 65-year-old patient (weight:NA) experienced the following symptoms/conditions: NA. The patient was prescribed Mucosta (dosage: NA), which was started on Mar 13, 2012. Concurrently used drugs:
|Pancytopenia, Interstitial Lung Disease|
This Interstitial Lung Disease Mucosta side effect was reported by a health professional from JAPAN on May 30, 2012. A male , 64 years of age, was treated with Mucosta. The patient presented the following health conditions:
|Productive Cough, Interstitial Lung Disease|
This is a Mucosta side effect report of a 69-year-old female patient (weight:NA) from JAPAN, suffering from the following symptoms/conditions: gastritis,diabetes mellitus,sputum retention,nasopharyngitis, who was treated with Mucosta (dosage:NA, start time: Feb 17, 2011), combined with:
|Lung Consolidation, Interstitial Lung Disease, Cardiac Failure Acute, Malaise|
A 82-year-old patient (weight: NA) from JAPAN with the following symptoms: NA started Mucosta (rebamipide) Tablet, 100 Mg treatment (dosage: NA) on Nov 17, 2008. Soon after starting Mucosta (rebamipide) Tablet, 100 Mg treatment, the consumer experienced several side effects, including:
|Infection, Pain In Extremity, Acute Respiratory Distress Syndrome, Interstitial Lung Disease, Musculoskeletal Pain, Depressed Level Of Consciousness, Intestinal Perforation|
A patient from JAPAN was prescribed and started Mucosta on Dec 16, 2011. Patient felt the following Mucosta side effects: infection, pain in extremity, acute respiratory distress syndrome, interstitial lung disease, musculoskeletal pain, depressed level of consciousness, intestinal perforation Additional patient health information: male , weighting 152.1 lb, The consumer reported the following symptoms: was diagnosed with
|Respiratory Failure, Interstitial Lung Disease|
This report suggests a potential Mucosta Interstitial Lung Disease side effect(s) that can have serious consequences. A 83-year-old female patient from JAPAN (weight:NA) was diagnosed with the following health condition(s): prophylaxis against gastrointestinal ulcer and used Mucosta (dosage: NA) starting May 09, 2011. Soon after starting Mucosta the patient began experiencing various side effects, including:
|White Blood Cell Count Decreased, Interstitial Lung Disease|
An adverse event was reported by a pharmacist on Jun 29, 2011 by a Female taking Mucosta (dosage: NA) . Location: JAPAN , weighting 108.0 lb, patient began experiencing various side effects, including: Directly after treatment started, patient experienced the unwanted or unexpected Mucosta side effects: white blood cell count decreased, interstitial lung disease. Additional medications/treatments:
Associated medications used:
|Interstitial Lung Disease|
This Interstitial Lung Disease problem was reported by a physician from JAPAN. A 77-year-old patient (weight: NA) was diagnosed with the following medical condition(s): gastritis,pancreatitis acute,sepsis,hypokalaemia.On Apr 23, 2011 a consumer started treatment with Mucosta (dosage: 100 Mg, 3x/day). The following drugs/medications were being taken at the same time:
|Interstitial Lung Disease, Lung Disorder|
This is a Mucosta side effect report of a 48-year-old patient (weight: NA) from JAPAN. The patient developed the following symptoms/conditions: gastritis,cancer pain,lung adenocarcinoma recurrent,hypertension and was treated with Mucosta (dosage: NA) starting Apr 08, 2010. Concurrently used drugs:
Mucosta Interstitial Lung Disease Causes and Reviews
Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.
Breathing in dust or other particles in the air is responsible for some types of interstitial lung diseases. Specific types include
- Black lung disease among coal miners, from inhaling coal dust
- Farmer's lung, from inhaling farm dust
- Asbestosis, from inhaling asbestos fibers
- Siderosis, from inhaling iron from mines or welding fumes
- Silicosis, from inhaling silica dust
Other causes include autoimmune diseases or occupational exposures to molds, gases, or fumes. Some types of interstitial lung disease have no known cause.
Treatment depends on the type of exposure and the stage of the disease. It may involve medicines, oxygen therapy, or a lung transplant in severe cases.
Mucosta Interstitial Lung Disease Reviews
|Mon, 03 May 2010|
|what is the nursing responsibilities of Mucosta?|
|Fri, 13 May 2011|
|Mucosta is the real protection for GI because its enhanced natural protection for GI, which is Mucosal GI Prostaglandin Endogen,,|
|Wed, 23 Feb 2011|
|my stomach kinda hurts|
|Fri, 08 Apr 2011|
|stomach severe pain|
|Sun, 19 Feb 2012|
|I had eperienced stomach discomfort for the past few weeks and had rashes in tounge also. My doctor prescribed me with Rabegen.On consuming this tablet i have eperienced muscle pain and feverish. Is this a side effect? can i continue with this drug or should i stop this atonce?please help me.....Ramesh|